Delivery Order SPE2DB20D1004-SPE2DB22FF6R5
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,500.18 for the supply of Lantus Solostar 100 unit/mL 3mL insulin pens. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 1, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor that...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $4,831.88 Firm Fixed Price Delivery Order for Lantus SoloStar 100 unit/mL 3mL insulin pens. The contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of December 2, 2021. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Lantus Solostar insulin pens (100 unit/ml, 3ml). The $8,313.20 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of January 2, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as the primary...
- The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $2,447.33 for the supply of Lantus Solostar insulin pens. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,455.03 for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML insulin delivery pens. The award was made by the Defense Logistics Agency (DLA), a major component of the Department of Defense responsible for providing medical products and supplies to military healthcare programs. The contract has a completion date of November 9, 2022 and is a Firm Fixed Price arrangement. No...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar insulin pens. The contract, valued at $2,671.20, has a completion date of March 8, 2022 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Lantus Solostar insulin pens to the U.S. government. The $1,119.16 firm fixed-price delivery order was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA). Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Lantus Solostar 100 unit/mL 3mL insulin pens. The $1,151.88 firm fixed price Delivery Order was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) on June 21, 2024, with a completion date of June 24, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lantus Solostar insulin pens. The $1,642.50 firm fixed-price contract has an ultimate completion date of August 11, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FS24B) for Lantus Solostar 100 unit/mL 3mL valued at $1,202.19. The award was made by the Defense Logistics Agency (DLA) on March 29, 2022, with a completion date of March 30, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB22FF6R5Delivery Order
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FF6R5) valued at $1,618.14 for the supply of Lantus Solostar 100 unit/ml 3ml insulin pens. The contract was awarded on May 18, 2022 by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, with a completion date of May 19, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This delivery order is one of the numerous orders placed under that IDC. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 5/18/22 |